COMMUNIQUÉS West-GlobeNewswire
 
      -   
  REVA to Hold First Quarter 2018 Financial Results Call02/05/2018
-   
  Onconova Therapeutics Announces Closing of $28.75 Million Upsized Underwritten Public Offering02/05/2018
-   
  IntelGenx Announces Proposed Private Placement01/05/2018
-   
  Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 201801/05/2018
-   
  National Research Corporation Announces First Quarter 2018 Results01/05/2018
-   
  Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market01/05/2018
-   
  Intercept to Announce First Quarter 2018 Financial Results on May 8, 2018 and Present at Upcoming Investor Conferences01/05/2018
-   
  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)01/05/2018
-   
  Immunovaccine Shareholders Approve Share Consolidation at 99.85%01/05/2018
-   
  Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research01/05/2018
-   
  Assure Holdings Corp. Announces Update01/05/2018
-   
  Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 201801/05/2018
-   
  Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference01/05/2018
-   
  Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results01/05/2018
-   
  OpGen Announces Date of First Quarter 2018 Financial Results Conference Call01/05/2018
-   
  Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma01/05/2018
-   
  Capital Senior Living Corporation Reports First Quarter 2018 Results01/05/2018
-   
  TESARO Announces Participation in Two Investor Conferences01/05/2018
-   
  Prothena to Report First Quarter 2018 Financial Results on May 801/05/2018
Pages